1. Home
  2. ARDX vs ESTA Comparison

ARDX vs ESTA Comparison

Compare ARDX & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.49

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Establishment Labs Holdings Inc.

ESTA

Establishment Labs Holdings Inc.

HOLD

Current Price

$65.20

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
ESTA
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
ARDX
ESTA
Price
$5.49
$65.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$15.14
$86.86
AVG Volume (30 Days)
3.5M
482.2K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.67
EPS
N/A
N/A
Revenue
$2,607,000.00
$61,208,000.00
Revenue This Year
$38.22
$28.04
Revenue Next Year
$33.85
$26.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
76.49
52 Week Low
$3.50
$26.56
52 Week High
$8.40
$83.31

Technical Indicators

Market Signals
Indicator
ARDX
ESTA
Relative Strength Index (RSI) 33.52 38.35
Support Level $4.81 $63.74
Resistance Level $6.23 $70.31
Average True Range (ATR) 0.26 2.97
MACD -0.05 -0.79
Stochastic Oscillator 13.07 22.31

Price Performance

Historical Comparison
ARDX
ESTA

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Share on Social Networks: